Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis.

Clinical and Translational Gastroenterology
Parkpoom PhatharacharukulEric S Orman

Abstract

Clostridioides difficile infection (CDI) is common in patients with cirrhosis and is associated with poor outcomes. CDI risk factors in this population have been well characterized; however, risk factors of recurrent CDI (R-CDI) after treatment have not been explored. We sought to estimate the incidence of R-CDI and its associated risk factors in patients with cirrhosis. We performed a cohort study of patients with cirrhosis hospitalized with CDI between 2012 and 2016. We collected patient characteristics, including detailed information on the CDI, features of the underlying liver disease, and outcomes including R-CDI, hospital readmission, and mortality. R-CDI was defined as CDI occurring 2-8 weeks after the initial episode. Cox proportional hazards model was used to identify variables independently associated with the outcomes. A total of 257 hospitalized patients with cirrhosis and CDI were included. CDI was community associated in 22.6%. The incidence of R-CDI was 11.9%. R-CDI was not significantly associated with medications at hospital admission or discharge. Independent risk factors of R-CDI included increased Charlson Comorbidity Index (hazard ratio [HR] 1.30; 95% confidence interval [CI]: 1.09-1.55) and use of lactulos...Continue Reading

References

Aug 1, 1973·The British Journal of Surgery·R N PughR Williams
Feb 15, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P S KamathW R Kim
Mar 17, 2001·Biometrics·G Heinze, M Schemper
Jun 30, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fred A ZarMelinda B Davis
Oct 22, 2009·The American Journal of Gastroenterology·Jasmohan S BajajRaymond G Hoffmann
Aug 4, 2010·Expert Review of Gastroenterology & Hepatology·Sahil Khanna, Darrell S Pardi
Feb 4, 2011·The New England Journal of Medicine·Thomas J LouieUNKNOWN OPT-80-003 Clinical Study Group
Feb 26, 2011·American Journal of Infection Control·Rada ShakovVincent A DeBari
Nov 4, 2011·The New England Journal of Medicine·Vivian G LooAndre Dascal
Apr 25, 2012·The American Journal of Gastroenterology·Chun Shing KwokYoon Kong Loke
Jul 19, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jasmohan S BajajUNKNOWN NACSELD
Jul 5, 2013·Clinical Microbiology Reviews·Carey-Ann D Burnham, Karen C Carroll
Sep 26, 2013·The American Journal of Gastroenterology·Daniel E FreedbergJulian A Abrams
Apr 5, 2014·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Marya D ZilberbergErik R Dubberke
May 7, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stuart JohnsonUNKNOWN Polymer Alternative for CDI Treatment (PACT) investigators
Jan 30, 2015·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Abhishek DeshpandeThomas G Fraser
Feb 26, 2015·The New England Journal of Medicine·Fernanda C LessaL Clifford McDonald
Apr 15, 2015·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Mohamed AbdelfatahHossam Kandil
Oct 7, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A TrifanE Miftode
Jan 28, 2017·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Anant AgarwallaYu-Xiao Yang
Jun 24, 2017·Journal of Clinical Gastroenterology·Elliot Z SmithCurtis K Argo
Oct 27, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E ReigadasE Bouza
Dec 2, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andi L ShaneLarry K Pickering
Feb 21, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L Clifford McDonaldMark H Wilcox
Apr 26, 2018·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Eric S OrmanNaga Chalasani
May 10, 2018·Epidemiology and Infection·Kierra M DotsonKevin W Garey

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Jennifer L KuntzGabriel J Escobar
Journal of Clinical Medicine
Guido Granata On Behalf Of The ReCloDi Recurrence Of Clostridioides Difficile Infection Study Group
© 2021 Meta ULC. All rights reserved